Nurse Victoria's peptide pop-up event claims, fact-checked

What did @victoriamysecret actually say?

At a large Los Angeles market, this nurse-entrepreneur sold what she called "vitamin and peptide injections" alongside fresh-pressed juices, framing the whole event around "the power of health and wellness" and preventative health. She sold out in under three hours and credited the success to purpose-driven motivation. That's the full claim set: peptide and vitamin injections, at a public pop-up, administered by a nurse, to a general walk-in crowd.

To be clear, she didn't claim to cure any disease. She didn't list specific peptides on camera or give dosing instructions. But the phrase "peptide injections" at a market stall carries enough regulatory and safety weight that it deserves serious unpacking, regardless of how inspiring the entrepreneurship story is.

Does the science back this up?

The science on peptides is real but preliminary. Most of the evidence does not yet support administering them to healthy people at a pop-up event without individualized medical assessment.

Peptides like BPC-157 have shown tissue-repair effects in rodent studies (Seiwerth et al., 2018, Current Pharmaceutical Design), but human clinical trial data is sparse and largely absent from peer-reviewed literature. GHK-Cu has legitimate wound-healing and anti-inflammatory data in vitro (Pickart et al., 2015, Journal of Aging Research), but that does not translate to a blanket endorsement for injecting it into walk-in customers. CJC-1295 and ipamorelin stimulate growth hormone release, which sounds appealing for recovery, but the FDA has not approved these compounds for general wellness use, and compounded versions vary significantly in purity and potency.

Vitamin injections have a stronger evidence base in specific deficiency contexts. B12 injections, for example, are well-supported for people with malabsorption conditions (Stabler, 2013, New England Journal of Medicine). For healthy people without a confirmed deficiency, the benefit of injected vitamins over oral supplementation is not well-established.

What did they get wrong (or right)?

She got one thing genuinely right: public interest in preventative health is real and growing, and nurses are often underutilized as health educators. The concern isn't her enthusiasm. It's the regulatory and clinical context around what she was actually doing.

Here's the problem. Administering injections, including peptides, outside a licensed medical facility typically requires a physician's order or collaborative practice agreement in most U.S. states, including California. California's Business and Professions Code is specific: nurses operate under physician oversight for procedures like injections unless a standing order or protocol is in place. A pop-up market is not a clinical setting. There is no intake process visible, no mention of allergy screening, no discussion of contraindications.

• Peptides like ipamorelin can affect endogenous hormone levels and interact with other medications.
• Injection-site infections are a real risk outside sterile clinical environments.
• The FDA has placed several peptides on a list of compounds that cannot be compounded by pharmacies for general use, including BPC-157 as of 2023.

The entrepreneurship framing is compelling, but "God's dream" is not a substitute for a supervising physician agreement and a proper intake protocol.

What should you actually know?

If you're considering peptide therapy, the pop-up market is not where that conversation should start. This is not about dismissing nurses as providers. Advanced practice nurses and even RNs under proper physician agreements can legally administer many treatments. The issue is the setting and the apparent absence of individualized clinical assessment.

Peptide therapy, when done through a licensed telehealth or clinical provider, involves lab work, a health history review, and a specific treatment plan. The FDA's 2023 guidance removed BPC-157 from the list of permissible compounded substances, meaning any provider still offering it is operating in a gray-to-red regulatory zone. Patients have a right to ask: Is this compound FDA-compliant? Who is the supervising physician? What is your adverse event protocol?

Fresh-pressed juice is fine. Vitamin injections with proper screening can be fine. But peptide injections sold at a market stall, even by a well-meaning nurse with real credentials, require a much harder look before you roll up your sleeve.